Fischer Laurent
SEC Form 4 insider trading activity
Fischer Laurent has filed 3 SEC Form 4 filings (5 transaction rows) across 2 companies, including MIRM, ADVM, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jun 2, 2026.
On the most recent filing, Fischer Laurent is listed as CEO, PRESIDENT AND DIRECTOR at Adverum Biotechnologies, Inc. Inside the rolling window, Fischer Laurent reported 2 open-market purchases totaling $554K in ADVM and no open-market sales. The largest disclosed transaction in the window is a purchase of 117,614 ADVM shares on Dec 8, 2025, worth $507K.
Companies traded
Other insiders at MIRM
Insider Buying
$554K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Fischer Laurent made?
Fischer Laurent has filed 3 SEC Form 4 filings (5 transaction rows) across 2 companies, including MIRM, ADVM since 2025.
Which companies does Fischer Laurent trade?
Fischer Laurent has filed SEC Form 4 disclosures for 2 companies, including MIRM, ADVM.
When was Fischer Laurent's most recent SEC Form 4 filing?
Fischer Laurent's most recent SEC Form 4 filing on Tracefour is dated Jun 2, 2026.
What is Fischer Laurent's total buy and sell value in the current window?
Inside the rolling retention window, Fischer Laurent bought $554K and sold $0 based on SEC Form 4 filings.
What was Fischer Laurent's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 117,614 ADVM shares on 2025-12-08, worth $507K, per SEC Form 4 filings.